(SPSB) SPDR Barclays Short Term - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A4748 • Short-Term Bond

SPSB: Bonds, Short-Term, Corporate, Securities, ETF

The SPDR Barclays Short Term Corporate Bond ETF (NYSE ARCA: SPSB) is designed to provide exposure to the short-term U.S. corporate bond market by tracking the performance of the Barclays U.S. 1-3 Year Corporate Bond Index. The fund invests at least 80% of its total assets in securities that are part of the index or exhibit similar economic characteristics. This includes high-quality, short-duration corporate bonds issued by U.S. companies, with maturities ranging from 1 to 3 years. By focusing on shorter maturities, the fund aims to reduce interest rate risk while providing regular income through bond interest payments.

The ETF is structured as a passively managed fund, replicating the indexs performance by holding a representative sample of its constituents. This approach minimizes tracking error and ensures that investors gain exposure to a diversified portfolio of short-term corporate debt. The funds holdings are diversified across various sectors, with a focus on investment-grade corporate bonds, though it may include some lower-rated securities as per the indexs methodology. The funds average maturity is typically aligned with the indexs range of 1 to 3 years, making it suitable for investors seeking stability and income with lower sensitivity to interest rate fluctuations.

Ticker Symbol: SPSB Exchange: NYSE ARCA Type: ETF Country Origin: USA ETF Category: Short-Term Bond Average Volume 20d: 3,191,450 Last Price: 30.03 SMA 20: 29.95 SMA 50: 29.87 SMA 200: 29.45 ATR: 0.07 AUM: $7,919.05M USD

Based on the provided data, the 3-month forecast for SPSB suggests a stable to slightly upward trajectory. The funds price is currently hovering above its 20-day SMA (29.95) but below its 50-day (29.87) and 200-day (29.45) SMAs, indicating a potential sideways trend in the near term. The low ATR of 0.07 reflects minimal price volatility, suggesting that the fund is likely to trade within a narrow range. Given its focus on short-term bonds and the current interest rate environment, SPSB is expected to maintain its value with modest upside potential.

Additional Sources for SPSB ETF

SPSB ETF Overview

Market Cap in USD 7,523m
Category Short-Term Bond
TER 0.04%
IPO / Inception 2009-12-16

SPSB ETF Ratings

Growth Rating 50.9
Fundamental -
Dividend Rating 75.2
Rel. Strength 8.35
Analysts -
Fair Price Momentum 29.86 USD
Fair Price DCF -

SPSB Dividends

Dividend Yield 12m 4.91%
Yield on Cost 5y 5.43%
Annual Growth 5y 18.86%
Payout Consistency 86.1%

SPSB Growth Ratios

Growth Correlation 3m 87.5%
Growth Correlation 12m 97.4%
Growth Correlation 5y 45.8%
CAGR 5y 2.26%
CAGR/Max DD 5y 0.38
Sharpe Ratio 12m 2.53
Alpha 1.84
Beta -0.004
Volatility 2.04%
Current Volume 4904k
Average Volume 20d 4020.8k
What is the price of SPSB stocks?
As of May 15, 2025, the stock is trading at USD 29.93 with a total of 4,904,008 shares traded.
Over the past week, the price has changed by -0.20%, over one month by +0.59%, over three months by +1.13% and over the past year by +6.00%.
Is SPDR Barclays Short Term a good stock to buy?
Partly, yes. Based on ValueRay Analyses, SPDR Barclays Short Term (NYSE ARCA:SPSB) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 50.91 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SPSB as of May 2025 is 29.86. This means that SPSB is currently overvalued and has a potential downside of -0.23%.
Is SPSB a buy, sell or hold?
SPDR Barclays Short Term has no consensus analysts rating.
What are the forecast for SPSB stock price target?
According to ValueRays Forecast Model, SPSB SPDR Barclays Short Term will be worth about 32.3 in May 2026. The stock is currently trading at 29.93. This means that the stock has a potential upside of +7.75%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 32.3 7.8%